Stories of Life With Esophageal Cancer: Roger, Ellen, and Jeff

Article

Compelling stories of esophageal cancer survivors.

This video was produced by The Esophageal Cancer Awareness Association. It features the compelling stories of EC survivors: former US Congresswoman Ellen Tauscher, Jeff Thomas and Roger Tunsley.

Newsletter

Stay up to date on recent advances in oncology nursing and patient care.

Subscribe Now!
Recent Videos
Image of a woman wearing a patterned shirt in front of a dark blue background
Photo of a woman wearing a blazer in front of an Oncology Nursing News backdrop
3 experts in this video
3 experts in this video
Photo of a white man with curly hair and in front of a blue Oncology Nursing News backdrop
Related Content
Photo of an APP talking to and empowering a patient

Case Study: Bridging the Gap for Patients With Metastatic CRC

Randi Kihnel, MSN, APRN, ACCNS-AG
June 13th 2025
Article

Advanced practice providers have the opportunity to instill hope in patients through education and personalized care.

The Vitals

What New Cancer Drugs Were Approved in 2023?

Lindsay Fischer
January 1st 2024
Podcast

In this special episode of The Vitals, we ring in the New Year 2024 by combing through 2023 FDA approvals.

Graphic of a clipboard that reads "FDA"

Zanubrutinib Tablets Greenlit by FDA for All Approved Indications

Bridget Hoyt
June 12th 2025
Article

An oral tablet formulation of zanubrutinib was approved for use in patients with certain lymphomas or leukemia and Waldenström macroglobulinemia.

The Vitals

Finley-Oliver Talks Talquetamab and Other Later Line Multiple Myeloma Therapies

Lindsay Fischer
December 14th 2023
Podcast

Beth Finley-Oliver, MSN, ARNP, AGNP-BC, recaps part of her presentation from the 2023 JADPRO meeting about caring for patients with high-risk multiple myeloma.

Anatomical image of a person with the gastrointestinal tract highlighted

Nivolumab/Ipilimumab To Be New MSI-H/dMMR mCRC Standard of Care

Jordyn Sava
June 12th 2025
Article

Lasting survival benefits vs chemotherapy or monotherapy were achieved with nivolumab and ipilimumab for patients MSI-H/ dMMR metastatic colorectal cancer.

Graphic that resembles a stamp of approval reading "FDA Approved"

Taletrectinib Approved by FDA for ROS1+ Non-Small Cell Lung Cancer

Bridget Hoyt
June 11th 2025
Article

The tyrosine kinase inhibitor taletrectinib has been approved for use in patients with ROS1-positive non-small cell lung cancer.